Recent large-scale human genetic studies and animal models have collectively established the central role of ANGPTL4 in the regulation of TG levels and cardiovascular diseases (Aryal et al., 2019; Dewey et al., 2016; Myocardial Infarction et al., 2016; Gusarova et al., 2018). Here, ANGPTL4 is linked to cardiovascular disorder.